Fariborz Kamal insider trades
Open-market stock purchases and sales by Fariborz Kamal, President & COO at 4D Molecular Therapeutics, Inc, from SEC Form 4 filings since Dec 15, 2020.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -53%.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- FDMT 4D Molecular Therapeutics, Inc: 1 buy, last Mar 6, 2025